Neurology

Article	Citations
Functional Status at 30 and 90 Days After Mild Ischemic Stroke (S12.004)	629
Long-term Treatment with Galcanezumab in 29 Patients with Chronic Migraine: Results from the 3-year Continued Access Program of the REGAIN Study (P1-1.Virtual)	230
Contributions of Purine Synthesis and Recycling During Brain Development: Relevance to Lesch Nyhan Disease (S39.009)	217
Eladocagene Exuparvovec Gene Therapy Improves Motor Development in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency (S39.006)	214
Degeneration of upper and lower motor neurons in a novel CSF-mediated animal model of sporadic ALS (P3-13.006)	182
Sex-specific lesion pattern of long-term functional outcome after stroke (P9-10.004)	181
Left Rostral Prefrontal Connectivity Links Thalamic Stimulation to Changes in Abstraction (N1.002)	163
Tremor and Quality of Life Following Thalamic Deep Brain Stimulation for Essential Tremor: 5-Year Outcomes. (P14-11.006)	163
Missed Opportunities to Prevent N-methyl-D-aspartate Receptor (NMDAR) Encephalitis in a DREAMer (P3-1.005)	158
The National TeleNeurology Program (NTNP): Targeting rural Veterans to provide equitable access to specialty care (P4-12.002)	154
Leadership and Professional Development Innovation in a Military Adult Neurology Residency Program to Enhance Medical Readiness (P10-6.002)	153
Antibody-Oligonucleotide Conjugates (AOCs) Demonstrate Potent and Durable Exon Skipping and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy (S23.003)	148
Social Support and Clinical Outcomes in Patients with Parkinson Disease After Deep Brain Stimulation (P2-11.002)	136
Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of Amyotrophic Lateral Sclerosis. (S15.002)	120
Acute Neurological Inflammatory Diseases in Colombia: A Multi-center Observational Study from Zika outbreak to SARS-CoV-2 pandemic (S3.002)	118
DAMS-Net: A Domain Adaptive Lesion Segmentation Framework in Patients with Multiple Sclerosis from Multiple Imaging Centers (P18-4.001)	116
Two Probable Creutzfeldt-Jakob Disease Cases Within One Month in a Single Hospital in Grand Rapids, Michigan (P11-12.005)	116
Proteomic profiling of sporadic late-onset nemaline myopathy (P15-13.001)	115
Neuroradiological profile of Rhinoorbitocerebral mucormycosis in COVID-19 pandemic. (S18.007)	113
Education, Early Life Socioeconomic Status, and Later Life Alzheimer’s Disease-Related Neuropathological Lesions (S20.008)	109
Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease: An update (P4-11.005)	108
Cerebral Venous Thrombosis: A Possible Complication of Clomiphene Therapy for in vitro Fertilization (P2-10.003)	105
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)	103
Primary Brain Tumours Masquerading as Autoimmune Neurological Disorders-A Possible Paraneoplastic Association? A Retrospective Case Series (P12-1.005)	100
Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis (S19.005)	97

Safety and Tolerability of Conversion to Siponimod With and Without Titration in Patients with Advancing Forms of Relapsing Multiple Sclerosis: Interim Results of the Phase 3b EXCHANGE Study (P7-4.007	97
A Pediatric Case of Severe, Treatment-Resistant, COVID-19 Associated Acute Longitudinally Extensive Transverse Myelitis with Masquerading Confounding Variables (P8-5.003)	95
Motor Impairment In Intracerebral Hemorrhage (P1-1.Virtual)	95
REM Sleep Distribution and Timing in Hypersomnia (P1-1.Virtual)	93
Frequent MAPT p.R406W Carriers with a Nonconforming FTD Phenotype in the Belgian Population (S20.006)	93
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation in Neurodegeneration via Modification of Extracellular Vesicles (S36.006)	92
Timing and Location of Injection-site Adverse Events With Fremanezumab in Patients With Migraine: A Pooled Analysis of Phase 3 Studies (P16-2.003)	91
Results for the Quality of Life in Epilepsy Scale From a Long-Term Safety Study of Diazepam Nasal Spray for Seizure Clusters (P13-8.001)	89
An Open Label Study of Poly-MVA to Treat Fatigue in ALS (P3-13.005)	88
Machine Learning-Based Prediction of New Multiple Sclerosis Lesion Formation Using Radiomic Features from Pre-Lesion Normal Appearing White Matter (S26.009)	88
Immune Mediated Bulbar Myasthenia Gravis Incited by SARS-CoV2 mRNA Vaccination. (P11-13.010)	85
Prescribing Patterns for Patients With Parkinson’s Disease in Long-Term Care Facilities (P11-11.002)	85
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy (S5.006)	83
Head-to-head comparison of tau and amyloid PET visual reads for differential diagnosis: An international, multi-center study (S20.003)	82
Decision Support for AAN Quality Measures (P10-5.005)	82
Clinical, Electrophysiological and Genetic Profile of Hereditary Spastic Paraplegia. (1602)	80
Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxias in Canada: A Multi-center Study (P1-1.Virtual)	79
The Association of Posterior Reversible Encephalopathy Syndrome with COVID-19: A Systematic Review (P1-1.Virtual)	79
Spatial Association between Myasthenia Gravis and Hazardous Waste Sites: A Statewide Planning and Research Cooperative System (SPARCS) Study (2002–2014) (P7-13.003)	78
Self-reported Perceptions of Medication Effectiveness in Subjects Receiving Lemborexant for up to 12 Months (P4-7.004)	78
Impact of Celecoxib Oral Solution on Symptomatic Improvements in the Acute Treatment of Migraine (P15-2.006)	78
Systematic Comparison of Diffusion MRI-Derived Conventional Single-Tensor and Advanced Voxel-Wise Metrics Towards Understanding White Matter Tract Disorganization Due to Repeated Head Impacts (P11-8.0	78
Baseline Characteristics and Demographics of Patients Enrolled in an Expanded Access Program for Efgartigimod in Adult Patients with Generalized Myasthenia Gravis (P3-1.001)	77
A Digital Telehealth for At-Home Gait Assessment: Protocol and Case Report in Multiple Sclerosis (1840)	76
Functional Parcellation of the Cingulate Gyrus in Epilepsy Surgical Planning: Electrical stimulation, Electrocorticography, and fMRI study (P4-8.005)	76
Occurrence of cognitive impairment in older adult patients with epilepsy (P17-8.001)	76
Influence of Istradefylline Treatment on Levodopa Dose Escalation in PD Patients from over 10 Years of Experience (P7-11.001)	76
Characteristics and Outcomes of Stroke Patients with Concurrent SARS-CoV-2 Infection from March 1, 2020 to February 28, 2021: An Analysis from the N3C Database (P11-10.007)	75
Increased Anxiety, Depression and Suicidal Ideation in Children with Neuromyelitis Optica (P3-5.002)	75
An Ethical Approach to Detecting Covert Consciousness (P17-7.004)	75
Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage (P12-10.008)	70
Choosing Multiple Headache Preventive Medications Wisely: A Comprehensive Analysis Of Reported Versus Theoretical Drug-Drug Interactions (P8-2.002)	68
Bioassay-confirmed Pathogenic De Novo ATP1A1 Variants Cause a Complex Neurodevelopmental Syndrome (S29.009)	66
Novel biomarkers for limb girdle muscular dystrophy (LGMD) (P1-1.Virtual)	66
Patient Satisfaction Is Associated With Positive Communications With Health Care Professionals: Interim Results From a Survey of an Online Migraine Community (P5-2.004)	65
Artificial intelligence identifies spectral biomarkers for use in adaptive deep brain stimulation in Parkinson’s disease (S16.004)	64
Bilateral Alien Limb and the Spectrum of Creutzfeldt-Jakob Disease Phenomenology: A Case Series and Review of the Literature. (P1-1.Virtual)	64
Reduced Reward Responsiveness: A Unique Phenotypic Presentation of Depressive Symptoms in Multiple Sclerosis (P10-4.002)	64
Adult-onset MELAS Syndrome Mimicking Autoimmune Encephalitis (P10-1.001)	64
BRAT1 Associated Leukodystrophy exacerbated by Lymphoma directed Chemotherapy (P13-9.005)	63
Predictors of Favorable Functional Outcome Following Acute Ischemic Stroke Secondary to M1/ICA Occlusion in the Extended Thrombectomy Time Window (P13-10.005)	63
Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC) (P18-12.005)	62
Deep Brain Stimulation Parameter Prediction using GuideXT and Traditional Monopolar Survey in Parkinson’s Disease Patients (P8-11.003)	62
The Motor Axon Threshold Variability Is Increased in Chronic Inflammatory Demyelinating Polyneuropathy (P8-13.009)	61
Attitudes Regarding Genetic and Risk Factor Screening for Parkinson’s Disease (PD) among Research Study Participants in the Parkinson’s Progression Markers Initiative (PPMI) (P8-11.005)	61
Real-World Experience of Perampanel Monotherapy in Epilepsy Patients with Focal-Onset and Generalized-Onset Seizures (P15-8.002)	61
Atypical presentation of asymmetric limb dystonia in a patient with CHAT gene mutation (P7-13.008)	61
Selective β2-Adrenoreceptor Agonists and Long-Term Parkinson’s Disease Risk (S12.010)	61
Facioscapulohumeral muscular dystrophy myopathologic dissection in 22 patients shows highly variable morphologic findings (P14-13.009)	60
Patients with Multiple Sclerosis Attempting Conception: Interim Analysis from PREG-MS and CANPREG-MS Prospective Pregnancy Registries. (P9-4.009)	60

The Impact of Implementing the SNIS Recommendations for the Care of COVID-19 Patients Undergoing Emergent Mechanical Thrombectomy (4619)	59
A Case Report of Second Degree Heart Block and Sinus Pauses after VNS Placement in Refractory Epilepsy (P8-8.002)	59
Anomalous Language Lateralization in Semantic Dementia: a Neurodevelopmental Hypothesis (P8-3.003)	59
Investigating proton magnetic resonance spectroscopy in African American and Caucasian multiple sclerosis patients (4898)	58
Seropositive Pediatric Autoimmune Encephalitis: A Single Center Experience (4955)	58
Infectious Causes of Chronic Meningitis in Neurosurgical Patients (S38.007)	58
Amyloid beta deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort (P1-1.Virtual)	58
Thermodynamic Indices of Brain Activity to Identify People with Good Cognitive Capacity (P4-6.002)	58
Distinguishing Quantitative EEG Correlates of Psychogenic Non-Epileptic Seizures versus Epilepsy (P1-1.Virtual)	57
TSPO-PET-measurable Microglial Activation Associates with Serum 3-hydroxykynurenine Levels in Multiple Sclerosis Patients (P14-4.007)	57
Diagnosis of Stroke and Prognosis of Interventions Using Imaging and Machine Learning (P1-1.Virtual)	56
Pyridostigmine as an Effective Treatment for Atonic Colon in Parkinson’s Disease (P13-11.007)	56
Association of EEG Findings with Clinical Outcome in Patients with Encephalitis (P14-8.004)	56
Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) Associated with Systemic T-Cell Lymphoma Responsive to Mycophenolate Mofetil (5014)	56
Re-evaluating Risk Factors, Incidence, and Outcome of Aneurysmal and Non-aneurysmal Subarachnoid Hemorrhage (P1-1.Virtual)	55
Unmet Treatment Needs in Migraine Among Those Seeking Care from Neurologists or Headache Specialists: Results of the OVERCOME US study (P17-2.002)	55
Resident Perceptions of the Utility and Applicability of Global Neurology Morning Reports (5073)	55
Hospital readmission rates among acute ischemic stroke survivors with severe mental illness (83)	54
Group Text Messaging as a Residency Teaching Tool in Outpatient Neurology (P11-6.006)	54
Thyromimetics improve disease endpoints and modulate potential target engagement biomarkers in rodent models of ALD and MS (P3-4.011)	54
The Implications of Upper Motor Neuron Burden in Multiple System Atrophy (2466)	54
Progressive Multifocal Leukoencephalopathy as the Initial Presenting Sign of Underlying Immune Abnormalities: A Series of 3 Cases. (P10-9.005)	54
Nocardia Spinal Abscess in the Immunocompetent Patient (P18-9.002)	53
Emergency Department Evaluation of Patients with Vertigo: HINTS and Neuroimaging (2650)	53
Patient Practices and Experiences During COVID-19 Among Individuals Across the United States Enrolled in MS LifeLines Patient Support Program (P1-1.Virtual)	53
Signatures of premature immunosenescence in patients with multiple sclerosis (P1-1.Virtual)	53
Temporal Mapping of Trigeminal Neuralgia Lesions to Symptom Onset in Multiple Sclerosis: When Do the Lesions Occur and What Do They Tell Us? (P16-4.001)	52
Preclinical Development of NRTX-1001, an Inhibitory Interneuron Cellular Therapeutic for the Treatment of Chronic Focal Epilepsy (S13.007)	52
Safety and Effectiveness of Eculizumab in Japanese Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance Study (P1-1.Vir	52
HSV-2 Vasculitis as a Cause of Ischemic Stroke and Intracerebral Hemorrhage: a Case Report (P1-1.Virtual)	52
Vitamin D is Associated with Visual Memory in Northern Adolescents (P4-6.006)	52
Integrated deep phenotypic and mutational approach defines EBF3-related HADD syndrome genotype-phenotype relationships (2850)	52
A clinical decision tool to evaluate eligibility for endovascular therapy upon transfer within a regional stroke center (16)	51
Erdheim-Chester Disease: A rare case with central nervous system involvement (P15-9.006)	49
Association Between COVID-19 Vaccination and Cerebrovascular Accidents in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.002)	49
Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid-to Later-Life: The Framingham Heart Study (P1-1.Virtual)	49
Association Between Paraneoplastic Rhombencephalitis and Hypertrophic Olivary Degeneration (2458)	49
Team is Brain: An Interdisciplinary Educational Initiative to Improve Stroke Care in the Emergency Department (4343)	49
VA National TeleNeurology Program: Patient Characteristics and Access to Care (S8.005)	48
A case of pediatric Idiopathic intracranial hypertension associated with aplastic anemia (P13-12.005)	48
EEG analysis of social cognition in cervical dystonia (P17-11.008)	48
Applicability of sNFL in Multiple Sclerosis as Additional Measure to Monitor Treatments in Clinical Practice and Implications in NEDA-3 Evaluation (S19.001)	48
A Comparison Of Primary Angioplasty versus Angioplasty with Stent Placement for Treatment of Internal Carotid Artery Occlusion in Acute Ischemic Stroke Settings (P4-10.006)	48
Variability of Plasma Levodopa Conveniently Reduced by More Frequent Administration of Smaller Doses of Carbidopa/Levodopa Using a Novel Functionally Scored Formulation (P7-11.002)	48
School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study (1441)	47
Severe Presentation of Neuromyelitis Optica with Positive Antibody Following COVID-19 Vaccination (P7-1.006)	47
Predicting behind-the-wheel driving behavior in PD through motor and cognitive testing in outpatient clinics (P14-3.004)	47
A Rare Case of Giant Cell Arteritis Presenting With Transient Polycranial Neuropathies (P6-12.004)	47
Frequency of New Onset Seizures Amongst Adult Hospitalized Patients with COVID-19; A Systematic Review and Meta-Analysis (S24.010)	47
Effects of sulfatide accumulation on peripheral nerves in metachromatic leukodystrophy (P3-5.001)	47
Identification of early ischemia on non-contrast CT head using artificial intelligence (S6.007)	46
The Impact of the Coronavirus Pandemic in Neurology Residency Clinic: A Single Program Experience (4608)	46
Iatrogenic Right Subclavian Artery injury after central line placement: Neuro-Endovascular treatment experience with Covered Stent (2820)	45
Impact of pre-existing small vessel disease on Motor Outcomes after Deep Brain Stimulation in Parkinson’s Disease (P5-11.002)	45
Impact of the Vega Healthcare Provider Report on Provider Satisfaction and Decision-Making Confidence in Simulated Patient Portal Visits for Migraine (2090)	45
Motor function in patients with neuropsychiatric manifestations of neurodegenerative disease treated with pimavanserin (4531)	45
Effect of multiple sclerosis patient genetic background on cerebral organoid cell populations. (4296)	45
A Comparison of Circulating microRNAs and Neurodegenerative Biomarkers in Traumatic Brain Injury (4287)	45
Primary Progressive Multiple Sclerosis: Retrospective Study of Incidence in Greater Manchester (P1-1.Virtual)	45
Increase in Polyneuropathy Disability Stage Does Not Predict Neuropathic Progression in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy Receiving Inotersen: Results from the NEU	45
Preferences and Experiences of Women with Epilepsy Regarding Sexual and Reproductive Health Care (P17-8.005)	45
Cross-sectional and longitudinal effects of APOE genotype on atrophy and tau burden in atypical Alzheimer’s disease (P9-3.003)	45
Sex-specific Differences in Stroke Epidemiology in Zambia (2108)	44
Real-World Effectiveness of Ubrogepant Among Participants With Prior Treatment Failure: Subgroup Analysis From the UNIVERSE Study (P12-2.001)	44
Accurate Test of Limb Isometric Strength (ATLIS) as an Outcome Measure in ALS and as a Marker of Upper Motor Neuron Involvement in Primary Lateral Sclerosis (S11.010)	44
Lest We Forget: Ammonia in Encephalopathic Cancer Patients (P1-1.Virtual)	43
Associations between Baseline Cognitive Function and Gait Outcomes after Treadmill Training in Parkinson disease (P1-1.Virtual)	43
Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010)	43
Brain Barriers: Elucidating Complex Language-Based Barriers to Neurological Care in Limited-English Proficiency, Refugee, and Immigrant Populations (P17-13.003)	43
A Two-Center, Parallel-Arm Randomized-Controlled Feasibility Trial Of A Goals-Of-Care Decision Aid For Surrogates Of Severe Acute Brain Injury Patients (2288)	43
Socio-epidemiological Factors associated with the Incidence of Cerebrospinal Meningitis in Sub-Saharan Africa (P18-2.005)	42
How Do Patients and Physicians Experience the Same Teleneurology Encounter? (5109)	42
Unraveling the Genetic Tapestry of a Village Legend	42
Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio? (S7.010)	42
Dissociative seizures across the adult lifespan: female sex, delay to diagnosis and disability (1742)	42
Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic (P18-10.009)	42
Physician Approaches to Anti-thrombotic Therapies for Acutely Symptomatic Carotid Stenosis: Insights from the Hot Carotid Qualitative Study (P1-1.Virtual)	42
Pre-pregnancy migraine and risk of adverse pregnancy outcomes (S4.003)	42
Concurrent Olaparib and Temozolomide for Recurrent Glioma (P5-9.005)	42
Continuous EEG Monitoring in Aneurysmal Subarachnoid Hemorrhage: Clinical Outcomes and Costs (2487)	41

Cannabis use and stroke in young people: A case report and review of the literature (4227)	41
Aging with MS - age related factors and socio-economic risks (2224)	41
Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2553)	41
NIH Toolbox Standing Balance Test as a new method to detect subtle balance impairment in patients with multiple sclerosis (2683)	41
The Positive Predictive Value of MOG Autoantibody Live Cell-Based Assay in a Tertiary Referral Center (4224)	40
How #Epilepsy is Viewed on Social Media (4204)	40
Improvements in Patient-reported Migraine Pain Intensity and Composite Migraine Symptoms With Fremanezumab in the Real World (2114)	40
History of Stroke Confers High Mortality among Middle Aged Patients with COVID-19 Infection: Results from the Louisville COVID-19 Study (4225)	40
Focused ultrasound ablation of the anterior thalamus for epilepsy (4586)	39
Evaluation of Intensive Versus Standard Blood Pressure Reduction and Association with Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis (S15.007)	39
Compound Mutations in IGHMBP2 are Associated with a Demyelinating Polyneuropathy (P10-13.007)	39
Dimethyl fumarate-induced changes in Lymphocyte Subpopulations could identify "NEDA" patients (4483)	39
Relevance of NODDI to Characterise in Vivo the Microstructural Abnormalities of Multiple Sclerosis Cortex and Cortical Lesions: A 3T Study (2560)	39
Neurofibromatosis Type 1 and Metastatic Testicular Germ Cell Tumor (P1-1.Virtual)	39
A Case of Thymoma Associated with Five Paraneoplastic Syndromes and Nine Autoantibodies (5102)	39
Factors Associated with Anxiety after Hemorrhagic Stroke (P1-1.Virtual)	39
Effect of 3,4-diaminopyridine phosphate in symptomatic SOD1-G93A mice (P1-1.Virtual)	39
Temporality and Causes of Mortality Among Patients Receiving Reperfusion Therapy for Large Vessel Occlusion (LVO) Strokes (2804)	38
A Neuropathologic Feature of Brain Aging: Multi-lumen Vascular Profiles (2750)	38
Long-Term Efficacy of Cenobamate by Concomitant Antiseizure Medication: Post-hoc Analysis of the C017 Open-label Extension Study (2351)	38
Is There Really a Relationship Between Hippocampal Atrophy and Cued Recall Deficits? (2202)	38
Clinical Diffusion Mismatch predicts Early Neurological Improvement after Late-time Window Endovascular Revascularization (2658)	38
Acute Encephalopathy is associated with worse outcomes in COVID-19 patients (2741)	38
Evolution of Lesions that Shrink or Disappear into Cerebrospinal Fluid (Atrophied T2 Lesion Volume) in Primary-Progressive Multiple Sclerosis: Results from the Phase III ORATORIO Study (107)	38
The ‘Gump sign’: An atypical presentation of NPH with involuntary running (4545)	37
Trends and predictors of peripheral CD19+ B-cell repopulation in patients treated with extended interval ocrelizumab dosing during COVID-19 pandemic (2813)	37
A Case of ATP1A2 Familial Hemiplegic Migraine Presenting with Unilateral Encephalopathy and a Cytotoxic Corpus Callosum Lesion (P1-1.Virtual)	37
Humoral immunological memory is retained in patients with multiple sclerosis receiving cladribine therapy (P6-4.008)	37
Use of Continuous Electroencephalogram (cEEG) in Critically Ill Patients (2851)	37
Impact of Patisiran on Activities of Daily Living and Functional Status in hATTR Amyloidosis (1493)	37
Effectiveness of epilepsy treatment with Cannabis Sativa derivatives in children with Dravet Syndrome – Systematic Review (P1-1.Virtual)	37
A Patient-Focused Survey to Assess the Effects of the COVID-19 Pandemic and Social Policies on People with Muscular Dystrophy (2930)	37
Increased Healthcare Cost and Mental Health Burden among Patients with Essential Tremor: A Retrospective Observational Study in A Large US Commercially Insured and Medicare Advantage Population (P15-1	36
The Canadian Neuromuscular Disease Registry: A national spinal muscular atrophy (SMA) registry for real world evidence (4420)	36
Frequency and predictors of obstructive sleep apnea in a cognitively impaired clinic population (5065)	36
Hemispheric Cortical Atrophy ipsilateral to Carotid Stenosis (N5.001)	36
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort treated with Nusinersen (4544)	36
Adherence and Compliance with Subcutaneous Administration of Ofatumumab in Relapsing Multiple Sclerosis (4521)	36
Efficacy and Safety of Ocrelizumab in Patients With RRMS With Suboptimal Response to Prior Disease-Modifying Therapies: 3-Year Data From CASTING and LIBERTO (LIBERTO 1-Year Interim Results) (P5-4.003)	36
Moyamoya Disease in African Americans: A Single-Center Experience (4860)	36
Safety and Efficacy of the Telestroke Drip-and-Stay Model: A systematic review and meta-analysis (1465)	36
Estimated migraine acute-therapy savings, from MMD reduction achieved with preventive treatment (2381)	36
The Role of Semantic Saliency in Reading Epilepsy: A Case Report (1466)	35
Acute seizure risk in encephalitis; analysis and modelling of 436 patients from two independent multi-centre cohorts (S38.008)	35
Prodromal Parkinson’s disease - insights from UK Biobank (2229)	35
Impact of Insomnia-Medication Adherence in Alzheimer’s Disease Patients with Comorbid Depression (1541)	35
Neurosyphilis Presenting as Acute Ischemic Stroke and Improvement with Thrombolytics (2859)	35
Progressive Apraxia of Speech: Delays to Diagnosis and Rates of Misdiagnosis (123)	35
Impact of pimavanserin on cognitive measures in patients with neurodegenerative disease (NDD): results from 4 placebo-controlled clinical studies (2369)	35
A Value Assessment of Diagnostic Modalities for Trigeminal Sensory Neuropathy (1456)	35
Characteristics and clinical outcomes of underserved minority patients with multiple sclerosis treated with peginterferon beta-1a or intramuscular interferon beta-1a in MS PATHS (2392)	35
Safety and efficacy of TAK-925 in adults with obstructive sleep apnea who experience excessive daytime sleepiness despite adequate use of CPAP (4278)	34
Abstract: Fast Neuro - Expedited Access to Neurology Clinic (2015)	34
Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection (P9-12.003)	34
COVID-19 outcomes in hospitalized patients with pre-existing neurodegenerative diseases in Chicagoland area (2361)	34
Retinal vasculopathy with cerebral leukodystrophy due to TREX-1 mutation: an important mimicker of CNS inflammatory disease (1591)	34
Levetiracetam and Lacosamide in the treatment of Non-Convulsive Status Epilepticus (1347)	34
Retrieved Arterial Clot Helps Guide Antibiotic Therapy in Infective Endocarditis (1807)	34
Evaluation of Epilepsy Patients to Ascertain Risk Factors for 30-day Hospital Readmission (4919)	34
A Rare Case of Co-occurrence of Astrocytoma and Oligodendroglioma (4975)	34
Changes the Transcriptional Activity of Genes Regulating Neurogenesis in the Blood of Patients with Thyroid Endocrine Pathology (4375)	34
Immunogenetic Risk Markers in Postural Orthostatic Tachycardia Syndrome (4709)	34
Chronic Comorbidities of Caregivers of Homebound Individuals with Advanced Parkinson’s Disease (2209)	34
Safety and Feasibility of Intrathecal Pembrolizumab Infusion in Refractory Triple Negative Breast Cancer with Leptomeningeal Disease (2946)	33
The Role of Carotid Ultrasound in Patients with Non-Focal Neurological Complaints (2197)	33
Inflammatory amyloid angiopathy: a series of clinical cases and a review of the literature (2507)	33
Worsening longitudinal reaction time trajectories using the MSReactor computerised battery predicts confirmed EDSS progression. (5219)	33
Comparison of Efficacy Outcomes in Trials Using a M207 in the Acute Treatment of a Single Migraine or Multiple Migraines (2136)	33
Neuronal Ceroid Lipofuscinosis Assessment Utilizing Virtual Visits During a Pandemic (2320)	33
Assessment of adrenal function after ACTH treatment in children with infantile spasms: a retrospective analysis of local practices and trends (4835)	33
Subjective sleep disturbances are not associated with objective cognitive functional impairment in Parkinson’s disease (4647)	32
Long-Term Soticlestat Treatment in Patients with Developmental and/or Epileptic Encephalopathies in the ENDYMION Ongoing Open-Label Extension Study (4197)	32
Analysis of the Duke Myasthenia Gravis (MG) Clinic Registry: Thymectomy (2602)	32
Impact of Multisite Pain on Activities of Daily Living in Older Adults: A Cross-sectional Analysis of Korean Longitudinal Study of Ageing (KLoSA) (1706)	32
Long-term Efficacy of Opicapone in the Reduction of ON-time with Troublesome Dyskinesia in Parkinson’s Disease Patients with Motor Fluctuations and Reporting Troublesome Dyskinesia (1609)	32
Evaluation of Diabetes Mellitus as a Risk Factor for Carpal Tunnel Syndrome (1666)	32
Does the NEOS Score Predict Outcomes in Pediatric Anti-NMDA Receptor Encephalitis Patients? (1860)	32
Evaluation of Cardiovascular Risks in Patients Treated With Longer-term Exposure to Galcanezumab (2344)	32
Criteria for management of spontaneous intracerebral hemorrhage without quaternary referrals (2513)	32
Comparing Free-Water Corrected and Uncorrected Single Tensor Diffusion MRI Measures in Individuals with Repetitive Head Impact (4648)	32
Anomalously warm weather and acute care visits in patients with multiple sclerosis: A retrospective study of privately insured individuals in the U.S. (1193)	32
Neurological Risks and Benefits of Medical Cannabis Ase: A Cross-sectional Analysis of Health Care Professionals’ Knowledge (1889)	32
Post-approval Safety of Subcutaneous Interferon β-1a in the Treatment of Multiple Sclerosis, with Particular Reference to Respiratory Viral Infections (1916)	32
A Retrospective Chart Review of Lymphocyte Reconstitution Among MS Patients After Discontinuation of Dimethyl Fumarate (2040)	32
An Educational Dilemma: Tableside Versus Bedside Rounding in Neurology Trainee Education (4394)	32
Age at Disease Onset Influences Gray Matter and White Matter Integrity in Multiple Sclerosis (2026)	32
Tabescent in Amyotrophic Lateral Sclerosis: Cacogeusia without Dysgeusia (1245)	32
Investigating the Genetic Characteristics of Hippocampal Volume and Plasma Aβ in a Chinese Community-Dwelling Population (P1-1.Virtual)	31
Cloning and overexpression of multi-domain enhancer protein p300, to study its involvement in childhood-diffuse intrinsic pontine glioma (DIPG) cell proliferation. (P13-9.003)	31
Headache associated with personal protective equipment in healthcare workers during COVID-19 outbreak in a referral centre in Mexico (5159)	31
Myelopathy in the Setting of Malignancy: The Importance of a Thoughtful Approach to Autoantibody Testing Based on Clinical Presentation (1295)	31
COVID-19 in Patients With Pre-existing Neurologic Disorders: Clinical Course and Outcomes (2608)	31
Creation of a Longitudinal, Clinical Undergraduate Pipeline Program to Engage Underrepresented Individuals in Neurology (4603)	31
A Case of Contrast-Induced Encephalopathy in The Setting of Acute Stroke Thrombolysis (P1-1.Virtual)	31
Analyses of the Effect of Disease Duration on the Efficacy and Safety of Siponimod in Patients with Active SPMS from the Phase 3 EXPAND Study (4649)	31